First, CNR1 and GPR55 mRNA expressions between different degrees of glioma malignancy, i.e., low-grade glioma vs. GBM, were not significantly different, but were higher than those in non-malignant brain (Figure 1A, B). This evidence concerns the gene GPR55 and glioblastoma.